Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study

Cyclophosphamide, doxorubicin, vincristine, and prednisolone plus rituximab (R-CHOP) is the standard treatment for patients with diffuse large B cell lymphoma (DLBCL). However, rituximab cannot be popularly applied in a considerable number of patients with DLBCL because of economic reasons. To devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Dongmei, Li, Qiu, Cao, Junning, Guo, Ye, Lv, Fangfang, Liu, Xiaojian, Wang, Biyun, Wang, Leiping, Luo, Zhiguo, Chang, Jianhua, Wu, Xianghua, Hong, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078098/
https://www.ncbi.nlm.nih.gov/pubmed/27129176
http://dx.doi.org/10.18632/oncotarget.8973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078098/
https://www.ncbi.nlm.nih.gov/pubmed/27129176
http://dx.doi.org/10.18632/oncotarget.8973

Ejemplares similares